New cholesterol drug tested right after heart attack to stop second one
NCT ID NCT07142265
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests whether starting inclisiran early after a heart attack can lower bad cholesterol and reduce the risk of another heart attack or stroke. About 300 adults in Russia who had a recent heart attack and have high cholesterol will receive inclisiran injections. Researchers will track heart events, cholesterol levels, and safety over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novartis Investigative Site
RECRUITINGCheboksary, 428000, Russia
-
Novartis Investigative Site
RECRUITINGGrozny, 364051, Russia
-
Novartis Investigative Site
RECRUITINGKaluga, 248000, Russia
-
Novartis Investigative Site
RECRUITINGKemerovo, 650002, Russia
-
Novartis Investigative Site
RECRUITINGKhanty-Mansiysk, 628012, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 105203, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 119607, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 121552, Russia
-
Novartis Investigative Site
RECRUITINGNovosibirsk, 630051, Russia
-
Novartis Investigative Site
RECRUITINGOrenburg, 460018, Russia
-
Novartis Investigative Site
RECRUITINGPenza, 440026, Russia
-
Novartis Investigative Site
RECRUITINGPetrozavodsk, 185019, Russia
-
Novartis Investigative Site
RECRUITINGRostov-on-Don, 344010, Russia
-
Novartis Investigative Site
RECRUITINGS Petersburg, 192242, Russia
-
Novartis Investigative Site
RECRUITINGSamara, 443070, Russia
-
Novartis Investigative Site
RECRUITINGSyktyvkar, 167981, Russia
-
Novartis Investigative Site
RECRUITINGTomsk, 634009, Russia
-
Novartis Investigative Site
RECRUITINGUlan-Ude, 670031, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict how well the heart heals after an attack?
- Could a hot bath after exercise help heal the heart?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Could a personal trainer cut heart attack deaths?
- Can a personalized exercise plan boost heart rehab for seniors?
- Can a 3D virtual world rehab your heart?